David A. Cory serves as Executive at Eiger BioPharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, David A. Cory has executed 12 insider transactions totaling $31.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 11, 2022 involved receiving (via award) 47,000 shares valued at $0.
David A. Cory currently holds 169,183 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Cory has been a net buyer of EIGR stock. They have purchased $31.6K and sold $0 worth of shares.
David A. Cory's most recent insider trade was on Mar 11, 2022, when they sold 47,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 5, 2020 | EIGR | $11.0K | Award | 1,500 | $7.31 | Discretionary |
| Sep 5, 2019 | EIGR | $11.9K | Award | 1,500 | $7.95 | Discretionary |
| Mar 5, 2019 | EIGR | $11.9K | Award | 1,500 | $7.95 | Discretionary |
| Feb 4, 2019 | EIGR | $3.9K | Purchase | 343 | $11.26 | Discretionary |
| Feb 4, 2019 | EIGR | $3.2K | Purchase | 227 | $14.13 | Discretionary |
| Sep 5, 2018 | EIGR | $11.9K | Award | 1,500 | $7.95 | Discretionary |
| Mar 5, 2018 | EIGR | $12.0K | Award | 1,500 | $8.03 | Discretionary |
| Sep 5, 2017 | EIGR | $14.8K | Award | 1,500 | $9.90 | Discretionary |
| Mar 6, 2017 | EIGR | $10.9K | Award | 1,325 | $8.20 | Discretionary |
| Aug 18, 2016 | EIGR | $24.5K | Purchase | 1,562 | $15.70 | Discretionary |